Investigational new drugs and ethical review: the adequacy of clinical research phases

Detalhes bibliográficos
Autor(a) principal: Goldim, José Roberto
Data de Publicação: 2007
Tipo de documento: Artigo
Idioma: por
Título da fonte: Clinical and Biomedical Research
Texto Completo: https://seer.ufrgs.br/index.php/hcpa/article/view/2073
Resumo: One of the most important warranties against abusive research procedures is the previous review by a Research Ethics Committee. New drugs research demands special attention in their evaluation, especially by the different phases that are involved in drug research. A comprehensive approach of characteristics, limits and aims of every research Project is fundamental to the evaluation
id UFRGS-20_38c58671e3cdca8b970aa2d6958c6597
oai_identifier_str oai:seer.ufrgs.br:article/2073
network_acronym_str UFRGS-20
network_name_str Clinical and Biomedical Research
repository_id_str
spelling Investigational new drugs and ethical review: the adequacy of clinical research phasesA avaliação ética da investigação científica de novas drogas: a importância da caracterização adequada das fases da pesquisa.Pesquisa farmacológicacomitês de ética em pesquisaPesquisaSaúdeOne of the most important warranties against abusive research procedures is the previous review by a Research Ethics Committee. New drugs research demands special attention in their evaluation, especially by the different phases that are involved in drug research. A comprehensive approach of characteristics, limits and aims of every research Project is fundamental to the evaluationA avaliação prévia por um Comitê de Ética em Pesquisa de todos os projetos de pesquisa envolvendo seres humanos é uma garantia contra eventuais abusos que possam vir a ser propostos. A pesquisa com novas drogas é das que mais requerem cuidados no processo de avaliação, especialmente por que se desenvolvem em diferentes fases conforme o nível de conhecimento sobre aspectos de segurança e eficácia envolvidos. A adequada compreensão sobre as características, finalidades e limites de cada uma das fases da pesquisa farmacológica é fundamental para a adequada avaliação dos projetos.HCPA/FAMED/UFRGS2007-07-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionPeer-reviewed ArticleAvaliado por paresapplication/pdfhttps://seer.ufrgs.br/index.php/hcpa/article/view/2073Clinical & Biomedical Research; Vol. 27 No. 1 (2007): Revista HCPAClinical and Biomedical Research; v. 27 n. 1 (2007): Revista HCPA2357-9730reponame:Clinical and Biomedical Researchinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSporhttps://seer.ufrgs.br/index.php/hcpa/article/view/2073/826Goldim, José Robertoinfo:eu-repo/semantics/openAccess2020-01-16T16:08:11Zoai:seer.ufrgs.br:article/2073Revistahttps://www.seer.ufrgs.br/index.php/hcpaPUBhttps://seer.ufrgs.br/index.php/hcpa/oai||cbr@hcpa.edu.br2357-97302357-9730opendoar:2020-01-16T16:08:11Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.none.fl_str_mv Investigational new drugs and ethical review: the adequacy of clinical research phases
A avaliação ética da investigação científica de novas drogas: a importância da caracterização adequada das fases da pesquisa.
title Investigational new drugs and ethical review: the adequacy of clinical research phases
spellingShingle Investigational new drugs and ethical review: the adequacy of clinical research phases
Goldim, José Roberto
Pesquisa farmacológica
comitês de ética em pesquisa
Pesquisa
Saúde
title_short Investigational new drugs and ethical review: the adequacy of clinical research phases
title_full Investigational new drugs and ethical review: the adequacy of clinical research phases
title_fullStr Investigational new drugs and ethical review: the adequacy of clinical research phases
title_full_unstemmed Investigational new drugs and ethical review: the adequacy of clinical research phases
title_sort Investigational new drugs and ethical review: the adequacy of clinical research phases
author Goldim, José Roberto
author_facet Goldim, José Roberto
author_role author
dc.contributor.author.fl_str_mv Goldim, José Roberto
dc.subject.por.fl_str_mv Pesquisa farmacológica
comitês de ética em pesquisa
Pesquisa
Saúde
topic Pesquisa farmacológica
comitês de ética em pesquisa
Pesquisa
Saúde
description One of the most important warranties against abusive research procedures is the previous review by a Research Ethics Committee. New drugs research demands special attention in their evaluation, especially by the different phases that are involved in drug research. A comprehensive approach of characteristics, limits and aims of every research Project is fundamental to the evaluation
publishDate 2007
dc.date.none.fl_str_mv 2007-07-12
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Peer-reviewed Article
Avaliado por pares
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://seer.ufrgs.br/index.php/hcpa/article/view/2073
url https://seer.ufrgs.br/index.php/hcpa/article/view/2073
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://seer.ufrgs.br/index.php/hcpa/article/view/2073/826
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv HCPA/FAMED/UFRGS
publisher.none.fl_str_mv HCPA/FAMED/UFRGS
dc.source.none.fl_str_mv Clinical & Biomedical Research; Vol. 27 No. 1 (2007): Revista HCPA
Clinical and Biomedical Research; v. 27 n. 1 (2007): Revista HCPA
2357-9730
reponame:Clinical and Biomedical Research
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Clinical and Biomedical Research
collection Clinical and Biomedical Research
repository.name.fl_str_mv Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv ||cbr@hcpa.edu.br
_version_ 1799767051229724673